This year’s AAIC in Amsterdam was packed with the latest research on Alzheimer’s. If you couldn’t go (or couldn’t go to everything you wanted to), we’ve provided summaries of the hottest topics.
Anti-amyloid antibodies: Hear about what’s new and what’s next for the first true DMTs for Alzheimer’s.
Novel therapeutics: What other DMTs are on the horizon?
Fluid biomarkers: New tests make measuring AD pathology easier and less invasive than ever before.
APOE4: What have we discovered about this key Alzheimer’s risk factor?
Glia: Hear about the key roles these cells play in AD.
Imaging guidelines: Learn the latest Appropriate Use Criteria for amyloid- and tau-PET, as well as how to monitor for ARIA in patients receiving lecanemab.
